Giovanni Marconi

1.4k total citations
58 papers, 360 citations indexed

About

Giovanni Marconi is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Giovanni Marconi has authored 58 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 23 papers in Molecular Biology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Giovanni Marconi's work include Acute Myeloid Leukemia Research (34 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). Giovanni Marconi is often cited by papers focused on Acute Myeloid Leukemia Research (34 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). Giovanni Marconi collaborates with scholars based in Italy, United States and United Kingdom. Giovanni Marconi's co-authors include Giovanni Martinelli, Giorgia Simonetti, Antonio Curti, Andrea Ghelli Luserna di Rorà, Sarah Parisi, Michèle Cavo, Martina Ghetti, Antonella Padella, Carmen Baldazzi and Cristina Papayannidis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Giovanni Marconi

51 papers receiving 358 citations

Peers

Giovanni Marconi
Naomi Kawashima Japan
Giambattista Bertani Italy
Patricia Kropf United States
Yogesh Jethava United States
Hyewon Lee South Korea
Stephan Bohl Germany
Kazutaka Ozeki Japan
Francesco Mendicino Italy
Tracy Murphy Canada
Yu‐Jun Dai China
Naomi Kawashima Japan
Giovanni Marconi
Citations per year, relative to Giovanni Marconi Giovanni Marconi (= 1×) peers Naomi Kawashima

Countries citing papers authored by Giovanni Marconi

Since Specialization
Citations

This map shows the geographic impact of Giovanni Marconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Marconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Marconi more than expected).

Fields of papers citing papers by Giovanni Marconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Marconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Marconi. The network helps show where Giovanni Marconi may publish in the future.

Co-authorship network of co-authors of Giovanni Marconi

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Marconi. A scholar is included among the top collaborators of Giovanni Marconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Marconi. Giovanni Marconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rondoni, Michela, Giovanni Marconi, Annalisa Nicoletti, et al.. (2025). Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype. Cancers. 17(7). 1213–1213.
2.
Ferrari, Anna, Eugenio Fonzi, Barbara Giannini, et al.. (2025). Unveiling Cryptic BCR-ABL1 Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid Malignancies. International Journal of Molecular Sciences. 26(18). 8812–8812.
3.
D’Addio, Alessandra, Michela Rondoni, Marzia Salvucci, et al.. (2025). PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study. Annals of Hematology. 104(9). 4487–4494.
4.
Rocchi, Serena, Beatrice Anna Zannetti, Giovanni Marconi, & Francesco Lanza. (2024). Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells. 13(10). 853–853. 3 indexed citations
5.
Marconi, Giovanni, et al.. (2024). Novel insights and therapeutic approaches in secondary AML. Frontiers in Oncology. 14. 1400461–1400461. 2 indexed citations
6.
Piciocchi, Alfonso, Giovanni Marconi, Stefano Soddu, et al.. (2024). Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients. SHILAP Revista de lepidopterología. 5(2). 353–359. 3 indexed citations
7.
Ghetti, Martina, Ivan Vannini, Maria Teresa Bochicchio, et al.. (2023). Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients. Biomedicine & Pharmacotherapy. 165. 115235–115235. 5 indexed citations
8.
Mallo, Mar, Heinz Tuechler, Leonor Arenillas, et al.. (2023). Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype. SHILAP Revista de lepidopterología. 4(2). 446–449. 3 indexed citations
9.
Bochicchio, Maria Teresa, Giovanni Marconi, Carmen Baldazzi, et al.. (2023). ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment. International Journal of Molecular Sciences. 25(1). 118–118. 1 indexed citations
10.
11.
Marconi, Giovanni, et al.. (2023). Biological therapy in elderly patients with acute myeloid leukemia. Expert Opinion on Biological Therapy. 23(2). 175–194. 2 indexed citations
12.
Kontro, Mika, Katharina Lang, Chiara Zingaretti, et al.. (2023). Personalizing precision medicine: Patients with AML perceptions about treatment decisions. Patient Education and Counseling. 115. 107883–107883. 1 indexed citations
13.
Monti, Manlio, et al.. (2023). Hemophagocytic lymphohistiocytosis in gastric cancer: A rare syndrome for the oncologist. Case report and brief review. Frontiers in Oncology. 13. 1010561–1010561. 2 indexed citations
14.
Padella, Antonella, Andrea Ghelli Luserna di Rorà, Giovanni Marconi, et al.. (2022). Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. Journal of Hematology & Oncology. 15(1). 10–10. 56 indexed citations
15.
Fontana, Maria Chiara, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.. (2021). Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. Biomedicines. 9(4). 388–388. 9 indexed citations
16.
Rorà, Andrea Ghelli Luserna di, Anna Ferrari, Carolina Terragna, et al.. (2019). Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia. Cancers. 11(11). 1654–1654. 22 indexed citations
17.
Corradi, Giulia, Carmen Baldazzi, Darina Očadlíková, et al.. (2018). Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Stem Cell Research & Therapy. 9(1). 271–271. 69 indexed citations
18.
Ciciarello, Marilena, Giulia Corradi, Giorgia Simonetti, et al.. (2018). Up-Regulation of Immune Tolerance Genes in Leukemic Mesenchymal Stromal Cells Is Induced By Acute Myeloid Leukemia Cells through an IFN-Gamma-Dependent Inflammatory Signaling. Blood. 132(Supplement 1). 2579–2579. 2 indexed citations
19.
Rorà, Andrea Ghelli Luserna di, Anna Ferrari, Valentina Robustelli, et al.. (2017). Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia. Blood. 130. 5049–5049. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naomi Kawashima Breakdown of academic impact, for papers by Giambattista Bertani Breakdown of academic impact, for papers by Patricia Kropf Breakdown of academic impact, for papers by Yogesh Jethava Breakdown of academic impact, for papers by Hyewon Lee Breakdown of academic impact, for papers by Stephan Bohl Breakdown of academic impact, for papers by Kazutaka Ozeki Breakdown of academic impact, for papers by Francesco Mendicino Breakdown of academic impact, for papers by Tracy Murphy Breakdown of academic impact, for papers by Yu‐Jun Dai
Rankless by CCL
2026